Skip to main content

Abstract

Thyroid disorders in women can be divided into two broad categories, disorders of thyroid function, such as hyperthyroidism or hypothyroidism; and disorders related to structural or morphological abnormalities. The major areas of concern here are thyroid nodules and thyroid cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hershman JM. Hyperthyroidism caused by chorionic gonadotropin. In Werner and Ingbar’s The Thyroid, 8th Ed (Braverman LE, Utiger RD, eds.). Lippincott-Raven Publishers, Philadelphia, 1996; p. 573–576.

    Google Scholar 

  2. Forbes G, Gorman CA, Brennan MD, et al. Ophthalmopathy of Graves’ disease: computerized volume measurements of the orbital fat and muscle. Neuroradiol 1986;7:651–656.

    CAS  Google Scholar 

  3. Sridama V, DeGroot LJ. Treatment of Graves’ disease and the course of opthalmopathy. Am J Med 1989;87:70–73.

    CAS  PubMed  Google Scholar 

  4. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A. Use of corticosteroids to prevent progression of Graves’ ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989;321:1349–1352.

    Article  CAS  PubMed  Google Scholar 

  5. Wartofsky L, Glinoer D, Solomon B, et al. Differences and similarities in the diagnosis and treatment of Graves’ disease in Europe, Japan and the United States. Thyroid 1991;1:129–135.

    Article  CAS  PubMed  Google Scholar 

  6. Pearce EN, Farwell A, Braverman LE. Thyroiditis. N Engl J Med 2003;348:2646–2655.

    Article  PubMed  Google Scholar 

  7. Stagnaro-Green A. Recognizing, understanding, and treating postpartum thyroiditis. Endocrinol Metab Clin North Am 2000;29(2):417–430.

    Article  CAS  PubMed  Google Scholar 

  8. Vaida B, Harris PE, Barrett P, Kendall-Taylor P. Corticosteroid therapy in Riedel’s thyroiditis. Postgrad Med J 1997;73:817–819.

    Article  Google Scholar 

  9. Ross DS, Daniels GH, Gouveia D. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160:526–534.

    Article  Google Scholar 

  10. Parle JV, Maisonneuve P, Sheppard MC, et al. Prediction of all cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001;358:861–865.

    Article  CAS  PubMed  Google Scholar 

  11. Hollowell GJ, Staehling NW, Falnders ED, et al. Serum TSH, T (4), and thyroid antibodies in US population (1988 to 1994): NHANES III, J Clin Endocrinol Metab 2002;87:489–499.

    Article  CAS  PubMed  Google Scholar 

  12. Burman KD. Hypothyroidism, Syllabus of Review of Endocrinology. Foundation for Advanced Education in the Sciences (FAES) at the National Institutes of Health, Oct. 2003; p. 594.

    Google Scholar 

  13. Vanderpump MP, Turnbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 1995;43:55–68.

    Article  CAS  Google Scholar 

  14. Hak AE, Pols HAP, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 2000;132:270–280.

    CAS  PubMed  Google Scholar 

  15. Cooper DS, Subclinical hypothyroidism. N Engl J Med 2001;345:260–265.

    Article  CAS  PubMed  Google Scholar 

  16. McCaffrey TV. Evaluation of the thyroid nodule, cancer control 2000;7:223–228.

    CAS  Google Scholar 

  17. Pearce EN, Braverman LE. Papillary thyroid microcarcinoma outcomes and implications for treatment. JCEM 2004;89:3710–3712.

    CAS  PubMed  Google Scholar 

  18. Burguera B, Gharib H. Thyroid incidentalomas, prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 2000;29:187–203.

    Article  CAS  PubMed  Google Scholar 

  19. Hodack SP, Burman KD. The calcitonin conundrum—is it time for routine measurements of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab 2004;89:511–514.

    Article  CAS  Google Scholar 

  20. Leenhardt L, Hejblum G, Franc B, et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 1999;84:24–28.

    Article  CAS  PubMed  Google Scholar 

  21. Yeh MW, Demircan O, Ituarte P, et al. False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid 2004;14:207–215.

    Article  PubMed  Google Scholar 

  22. de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, et al. Cystic thyroid nodules. The dilemma of malignant lesions. Arch Intern Med 1990;150:1422–1427.

    Article  PubMed  Google Scholar 

  23. Alexander EK, Hurwitz S, Heering JP, et al. Natural history of benign solid and cystic thyroid nodules. Ann Intern Med 2003;138:315–318.

    PubMed  Google Scholar 

  24. Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998;128:386–394.

    CAS  PubMed  Google Scholar 

  25. Zelmanovitz F, Genro S, Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 1998;83:3881–3885.

    Article  CAS  PubMed  Google Scholar 

  26. Robbins J, Merino MJ, Boice JD, et al. Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 1991;115:133–147.

    CAS  PubMed  Google Scholar 

  27. Giuffrida D, Gharib H. Current diagnosis and management of medullary thyroid carcinoma. Ann Oncol 1998;9:695–701.

    Article  CAS  PubMed  Google Scholar 

  28. Spencer CA, Wang CC. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls. Endocrinol Metab Clin North Am 1995;24:841–863.

    CAS  PubMed  Google Scholar 

  29. Juweid M, Sharkey RM, Behr T, et al. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. J Clin Oncol 1996;14:1209–1217.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Farooqi, M.H., Jabbour, S.A. (2008). Thyroid Disorders. In: Clouse, A.L., Sherif, K. (eds) Women’s Health in Clinical Practice. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-469-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-469-8_13

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-631-3

  • Online ISBN: 978-1-59745-469-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics